Infection Prevention

Infection Prevention

The purpose of our Infection Prevention Program is to control and prevent the spread of infectious diseases at Seattle Cancer Care Alliance (SCCA). This is done by monitoring infections and implementing control measures through the education of patients, visitors and employees. The goal of the Infection Prevention Program is to maintain the safest possible environment for patients, visitors, and employees.

Infection Prevention Team

  • Steven Pergam, MD, MPH, Infection Prevention Medical Director
  • Julie Knight, RN, Infection Prevention Coordinator
  • Kim MacLeod, Infection Prevention Coordinator
  • Karen Chadduck, CPHQ, Infection Prevention Manager
  • Debra Mattson, PC-C, Physician Assistant
  • Leah Yoke, PA-C, Physician Assistant

Infection Prevention Committee

The SCCA Infection Prevention Committee is comprised of representatives from specialty areas throughout SCCA. The committee meets monthly to evaluate policies, review current infection-prevention programs, and discuss current infection-prevention concerns.

Infection Prevention Activities


SCCA has the first surveillance system for tracking outpatient infections among comprehensive cancer centers. The surveillance system tracks bacterial, viral and fungal infections among outpatients. Trends in infections are plotted and analyzed in real time.

Outbreak Investigation

Any unusual clustering of infections in patients or staff is investigated in order to identify potential problems. Recommendations are then made to prevent the spread of infection.


The Infection Prevention Team is available to provide consultative services to patients and employees regarding infection control and prevention.


The program provides education to patients and employees regarding key infection-prevention topics, including (in PDF format):

Planning for Emerging Threats

The Infection Prevention Team works in collaboration with Public Health–Seattle & King County to plan for emerging infectious disease threats, including antibiotic-resistant infections and pandemic influenza.